title: [Treatment of peptic ulcer with sucralfate].
abstract: Sucralfate made in Bulgaria (Farmaphim) and its Yugoslavian analogue venter have been tried in gastroduodenal ulcer. The drugs were given per os (1 g, 1 tablet) 4 times a day before meals for 20 days. Sucralfate treatment was assigned to 26 patients with gastric and 26 with duodenal ulcer. The other 20 gastric ulcer patients received venter. 10 patients with gastric and 20 with duodenal ulcer entered the control group receiving placebo. Attenuation of the symptoms was reported as early as on day 4 of the treatment in 85-100% of the patients both with gastric and duodenal ulcer. The 20-day course of sucralfate treatment brought about a complete epithelization on gastric ulcer in 54% while in venter treatment in 55% of those treated versus placebo group 10%. Duodenal ulcer epithelization occurred in sucralfate-treated group in 58% against placebo group 17%. The differences in treatment results between sucralfate and venter are immaterial, whereas against placebo they are significant (p less than 0.05). Side effects were not serious.
authors.forename: Kh
authors.initials: Kh
authors.lastname: Brailski
authors.forename: A
authors.initials: A
authors.lastname: Mendizova
authors.forename: V
authors.initials: V
authors.lastname: Matov
authors.forename: B
authors.initials: B
authors.lastname: Dimitrov
mesh_terms: D000328:Adult; D000368:Aged; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000503:physiopathology; D010919:Placebos; D013392:Sucralfate / Q000008:administration & dosage / Q000627:therapeutic use*; D013607:Tablets; D013997:Time Factors; D014945:Wound Healing / Q000187:drug effects / Q000502:physiology
chemical_list: D000897:Anti-Ulcer Agents; D010919:Placebos; D013607:Tablets; D013392:Sucralfate
vernacular_title: Lechenie iazvennoĭ bolezni sukral'fatom.